BACKGROUND: There is an association between adiposity and asthma prevalence, but the relationship to asthma control is unclear. OBJECTIVES: We sought to understand the relationships among adiposity, sex, and asthma control in inner-city adolescents with asthma. METHODS: We prospectively followed 368 adolescents with moderate-to-severe asthma (ages 12-20 years) living in 10 urban areas for 1 year. Asthma symptoms and exacerbations were recorded, and pulmonary function and exhaled nitric oxide levels were measured every 6 weeks. Adiposity measures (body mass index [BMI] and dual-energy X-ray absorptiometric scans) were made, and blood was collected for measurement of allergy markers, adiponectin, leptin, TNF-alpha, IL-6, and C-reactive protein levels. RESULTS: More than 60% of female subjects and 50% of male subjects were above the 85th percentile of BMI for age. Higher BMI was associated with more symptom days (R = 0.18, P = .02) and exacerbations (R = 0.18, P = .06) among female subjects only. Adiponectin was inversely related to asthma symptoms (R = -0.18, P < .05) and exacerbations (R = -0.20, P < .05) and positively with FEV(1)/forced vital capacity ratio (R = 0.15, P < .05) in male subjects only independent of body size. There was no relationship between adiposity or adipokines and total IgE levels, blood eosinophil counts, and exhaled nitric oxide levels. Dual-energy X-ray absorptiometry provided little additional value in relating adiposity to asthma outcome in this population of adolescents. CONCLUSION: Adiposity is associated with poorer asthma control in female subjects. Adiponectin is associated with improved asthma control in male subjects.
BACKGROUND: There is an association between adiposity and asthma prevalence, but the relationship to asthma control is unclear. OBJECTIVES: We sought to understand the relationships among adiposity, sex, and asthma control in inner-city adolescents with asthma. METHODS: We prospectively followed 368 adolescents with moderate-to-severe asthma (ages 12-20 years) living in 10 urban areas for 1 year. Asthma symptoms and exacerbations were recorded, and pulmonary function and exhaled nitric oxide levels were measured every 6 weeks. Adiposity measures (body mass index [BMI] and dual-energy X-ray absorptiometric scans) were made, and blood was collected for measurement of allergy markers, adiponectin, leptin, TNF-alpha, IL-6, and C-reactive protein levels. RESULTS: More than 60% of female subjects and 50% of male subjects were above the 85th percentile of BMI for age. Higher BMI was associated with more symptom days (R = 0.18, P = .02) and exacerbations (R = 0.18, P = .06) among female subjects only. Adiponectin was inversely related to asthma symptoms (R = -0.18, P < .05) and exacerbations (R = -0.20, P < .05) and positively with FEV(1)/forced vital capacity ratio (R = 0.15, P < .05) in male subjects only independent of body size. There was no relationship between adiposity or adipokines and total IgE levels, blood eosinophil counts, and exhaled nitric oxide levels. Dual-energy X-ray absorptiometry provided little additional value in relating adiposity to asthma outcome in this population of adolescents. CONCLUSION: Adiposity is associated with poorer asthma control in female subjects. Adiponectin is associated with improved asthma control in male subjects.
Authors: Y Arita; S Kihara; N Ouchi; M Takahashi; K Maeda; J Miyagawa; K Hotta; I Shimomura; T Nakamura; K Miyaoka; H Kuriyama; M Nishida; S Yamashita; K Okubo; K Matsubara; M Muraguchi; Y Ohmoto; T Funahashi; Y Matsuzawa Journal: Biochem Biophys Res Commun Date: 1999-04-02 Impact factor: 3.575
Authors: M Rosenbaum; M Nicolson; J Hirsch; S B Heymsfield; D Gallagher; F Chu; R L Leibel Journal: J Clin Endocrinol Metab Date: 1996-09 Impact factor: 5.958
Authors: Robert J Hancox; Barry J Milne; Richie Poulton; D Robin Taylor; Justina M Greene; Christene R McLachlan; Jan O Cowan; Erin M Flannery; G Peter Herbison; Malcolm R Sears Journal: Am J Respir Crit Care Med Date: 2004-11-19 Impact factor: 21.405
Authors: Stuart P Weisberg; Daniel McCann; Manisha Desai; Michael Rosenbaum; Rudolph L Leibel; Anthony W Ferrante Journal: J Clin Invest Date: 2003-12 Impact factor: 14.808
Authors: Akshay Sood; Clifford Qualls; Mark Schuyler; Bharat Thyagarajan; Michael W Steffes; Lewis J Smith; David R Jacobs Journal: Am J Respir Crit Care Med Date: 2012-04-06 Impact factor: 21.405
Authors: Njira L Lugogo; John W Hollingsworth; Druhan L Howell; Loretta G Que; Dave Francisco; Tony D Church; Erin N Potts-Kant; Jennifer L Ingram; Ying Wang; Sin-Ho Jung; Monica Kraft Journal: Am J Respir Crit Care Med Date: 2012-07-05 Impact factor: 21.405
Authors: Jason E Lang; Janet T Holbrook; Robert A Wise; Anne E Dixon; W Gerald Teague; Christine Y Wei; Charles G Irvin; David Shade; John J Lima Journal: Pediatr Pulmonol Date: 2012-11-09
Authors: Kim D Lu; Krikor Manoukian; Shlomit Radom-Aizik; Dan M Cooper; Stanley P Galant Journal: Pediatr Exerc Sci Date: 2015-11-30 Impact factor: 2.333